methane has been researched along with pyrazinamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deka, RC; Rajkhowa, S; Saikia, N | 1 |
| Duckett, SB; Fekete, M; Hugh Perry, V; Iali, W; Manoharan, A; Norcott, P; Rayner, PJ | 1 |
2 other study(ies) available for methane and pyrazinamide
| Article | Year |
|---|---|
Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein.
Topics: Amidohydrolases; Antitubercular Agents; Crystallography, X-Ray; Drug Carriers; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Nanotubes, Carbon; Protein Conformation; Pyrazinamide; Tuberculosis | 2013 |
Catalyst-Substrate Effects on Biocompatible SABRE Hyperpolarization.
Topics: Antitubercular Agents; Biocompatible Materials; Catalysis; Cell Line, Tumor; Cell Survival; Coordination Complexes; Deuterium; Humans; Iridium; Isoniazid; Methane; Pyrazinamide; Substrate Specificity | 2019 |